P16083 (NQO2_HUMAN) Homo sapiens (Human)

Ribosyldihydronicotinamide dehydrogenase [quinone] UniProtKBInterProSTRINGInteractive Modelling

231 aa; Sequence (Fasta)

Available Structures

68 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Reduced quinone reductase 2 in complex with chloroquinehomo-2-mer2-231
ZN;FAD;CLQ;
Assess
Oxidized quinone reductase 2 in complex with primaquinehomo-2-mer2-231
ZN;FAD;1PQ;GOL;
Assess
Oxidized quinone reductase 2 in complex with chloroquinehomo-2-mer2-231
FAD;0TX;ZN;
Assess
Oxidized quinone reductase 2 in complex with CK2 inhibitor DMAThomo-2-mer2-231
ZN;FAD;K25;
Assess
Crystal Structure of Quinone Reductase IIhomo-2-mer2-231
ZN;FAD;ML1;
Assess
Crystal structure analysis of QR2 in complex with resveratrolhomo-2-mer2-231
ZN;FAD;STL;
Assess
Design, Synthesis and Biological Evaluation of Potent Quinoline and Pyrroloquinoline Ammosamide Ana…homo-2-mer2-231
ZN;FAD;465;GOL;
Assess
Quinone Reductase 2 in Complex with Cancer Prodrug CB1954homo-2-mer2-231
ZN;FAD;CB1;
Assess
Design, Synthesis and Biological Evaluation of Potetent Quinoline and Pyrroloquinoline Ammosamide A…homo-2-mer2-231
ZN;FAD;UXH;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;YTR;
Assess
Casimiroin analog inhibitor of quinone reductase 2homo-2-mer2-231
ZN;EWQ;FAD;
Assess
Crystal Structure of Quinone Reductase IIhomo-2-mer2-231
FAD;ML2;ZN;CL;GOL;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;MZX;
Assess
Crystal Structure of Quinone Reductase IIhomo-2-mer2-231
FAD;ML1;ZN;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;ZXZ;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;HGZ;
Assess
Crystal Structure of Quinone Reductase IIhomo-2-mer2-231
FAD;ML1;ZN;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;MZX;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;RZW;
Assess
Reduced quinone reductase 2 in complex with CK2 inhibitor DMAThomo-2-mer2-231
ZN;FAD;K25;
Assess
Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory activi…homo-2-mer2-231
ZN;XM5;FAD;
Assess
Reduced quinone reductase 2 in complex with acridine orangehomo-2-mer2-231
ZN;FAD;AO;
Assess
Oxidized quinone reductase 2 in complex with ethidiumhomo-2-mer2-231
ZN;FAD;ET;SO4;
Assess
Reduced quinone reductase 2 in complex with ethidiumhomo-2-mer2-231
ZN;FAD;ET;
Assess
Oxidized quinone reductase 2 in complex with acridine orangehomo-2-mer2-231
ZN;FAD;AO;
Assess
Crystal Structure of Quinone Reductase II in complex with a 2-(4-methoxy-phenyl)-5-methoxy-indol-3-…homo-2-mer2-231
ZN;FAD;3ZV;SO4;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;A7B;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;M42;
Assess
Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensationhomo-2-mer2-231
ZN;GOL;FAD;M49;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;VAP;
Assess
Oxidized quinone reductase 2 in complex with CK2 inhibitor TBBzhomo-2-mer2-231
ZN;FAD;K17;
Assess
Oxidized quinone reductase 2 in complex with doxorubicinhomo-2-mer2-231
ZN;FAD;DM2;
Assess
Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory activi…homo-2-mer2-231
MXX;FAD;ZN;
Assess
Binding of anti-cancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structu…homo-2-mer2-231
ZN;FAD;CB1;
Assess
Crystal structure of quinone reductase 2 in complex with the indolequinone MAC627homo-2-mer2-231
ZN;FAD;O73;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;VVV;FAD;
Assess
HUMAN QUINONE REDUCTASE TYPE 2homo-2-mer2-231
ZN;FAD;
Assess
Quinone Reductase 2 in Complex with Dopaminehomo-2-mer2-231
ZN;FAD;LDP;
Assess
Human quinone oxidoreductase 2 (NQO2) in complex with the cytostatic prodrug CB1954homo-2-mer2-231
ZN;FAD;CB1;
Assess
Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensationhomo-2-mer2-231
ZN;FAD;372;GOL;
Assess
Crystal Structure of Quinone Reductase IIhomo-2-mer2-231
FAD;ML2;ZN;
Assess
X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to…homo-2-mer2-231
ZN;FAD;A2Z;
Assess
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar…homo-2-mer2-231
ZN;FAD;79X;
Assess
HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONEhomo-2-mer2-231
ZN;FAD;VK3;
Assess
Quinone Reductase 2 in complex with adrenochromehomo-2-mer2-231
ZN;FAD;AD1;
Assess
The value crystal structure of apo quinone reductase 2 at 1.35Ahomo-2-mer3-231
GOL;ZN;
Assess
The value 'crystal structure of fad quinone reductase 2 at 1.45Ahomo-2-mer3-231
GOL;FAD;ZN;
Assess
Crystal Structure of Quinone Reductase II in complex with 2-(4-aminophenyl)-5-methoxy-1-oxy-indol-3…homo-2-mer3-231
ZN;FAD;3ZU;SO4;
Assess
Crystal structure of FMN quinone reductase 2 in complex with melatonin at 1.55Ahomo-2-mer3-231
FMN;ZN;ML1;
Assess
Crystal structure of fad quinone reductase 2 in complex with resveratrol at 1.6Ahomo-2-mer3-231
FAD;STL;ZN;GOL;
Assess
Structure of the human quinone reductase 2 (NQO2) in complex with imiquimodhomo-2-mer3-231
ZN;FAD;6T0;SO4;
Assess
CRYSTAL STRUCTURE OF FMN QUINONE REDUCTASE 2 IN COMPLEX WITH RESVERATROL AT 1.85Ahomo-2-mer3-231
FMN;STL;ZN;
Assess
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar…homo-2-mer3-231
ZN;FAD;695;
Assess
QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive …homo-2-mer2-230
ZN;FAD;SO4;V1Z;
Assess
Crystal structure of fad quinone reductase 2 in complex with melatonin at 1.4Ahomo-2-mer3-230
FAD;ML1;ZN;
Assess
Structure of the human quinone reductase 2 (NQO2) in complex with crenolanibhomo-2-mer3-230
ZN;FAD;6T2;
Assess
Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 6a1homo-2-mer3-230
ZN;FAD;6A1;IMD;
Assess
Crystal structure of fmn quinone reductase 2 AT 1.55Ahomo-2-mer4-231
FMN;ZN;
Assess
Structure of the human quinone reductase 2 (NQO2) in complex with to CL097homo-2-mer3-230
ZN;FAD;SO4;C09;
Assess
Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 5a1homo-2-mer3-230
ZN;FAD;TE7;IMD;
Assess
Quinone Reductase 2homo-2-mer3-230
ZN;FAD;STI;MRD;
Assess
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar…homo-2-mer3-230
ZN;FAD;4X4;
Assess
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar…homo-2-mer3-230
ZN;FAD;XRA;
Assess
Structure of the human quinone reductase 2 (NQO2) in complex with volitinibhomo-2-mer3-230
ZN;FAD;V0L;
Assess
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar…homo-2-mer3-230
ZN;MZC;FAD;
Assess
Quinone Oxidoreductase (NQ02) bound to NSC13000homo-2-mer3-230
ZN;FAD;AA;
Assess
X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar…homo-2-mer3-230
ZN;FAD;52X;
Assess
Structure of the human quinone reductase 2 (NQO2) in complex with pacritinibhomo-2-mer4-230
FAD;6T3;SO4;ZN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4fgl.1.Ahomo-2-mer0.902-231
ZN;FAD;CLQ;99.57
Assess